CME Live Webinar

Updated Guidelines for the management of Intermediate Hyperglycaemia (IH)/Type 2 Diabetes (T2D), 2025

28 May 2026
from 11.00 to 12.00 CEST

On demand session Final Programme
scroll-down-icon
WATCH THE ON DEMAND SESSION

Click to watch the Pre-webinar interview

DOWNLOAD INFOGRAPHIC

Overview

Several of the planned activities aim to educate healthcare professionals about the new Global International Diabetes Federation (IDF) 2025 clinical practice recommendations [Ceriello, 2025; Colagiuri, 2025; Colagiuri, 2025] and consensus statement from the South-East Asian regions on the primary prevention of diabetes in people with IH [Ramachandran, 2025] that advocate for ‘optimal’ or ‘basic’ care provision and a more individualized or community level, 3-step approach for screening, IH diagnosis and treatment design/delivery for each person with IH or T2D. The 1-h oral glucose tolerance (OGTT) test is proposed to be a more accurate indicator of IH based on the person’s glycaemic status [Colagiuri, 2025; Bergman, 2024]. Lifestyle changes and medications, including metformin as the foundation treatment, are effective in those individuals at high-risk of developing T2D, especially those with gestational diabetes (GDM) or BMI>35 [Colagiuri, 2025; Colagiuri, 2025]. Indeed, metformin remains the foundation and 1st line monotherapy due to its global availability, efficacy, low hypoglycaemic risk, cost-effectiveness and long-term cardiovascular (CV) benefits [Colagiuri, 2025].

Learning Objectives

At the end of the activity, learners should be able to:

  • • Have knowledge of the 2025 updated Global International Diabetes Federation (IDF) guidance
  • • Know the new guidance for South-East Asia primary prevention of IH, 2025

Target Audience

HCPs managing patients with T2D including clinicians involved in endocrinology, particularly diabetes, pre-diabetes/IH; obesity management and general practice.

Language

English with simultaneous translation into Spanish and Chinese

Continuing Medical Education

The Updated guidelines for the management of Intermediate Hyperglycaemia (IH)/Type2 Diabetes (T2D), 2025 – Virtual, Italy, 28/05/2026 – 28/05/2026 organized by MedEA Medical Education Academy has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

uems-eaccme-logo

The content of Updated guidelines for the management of Intermediate Hyperglycaemia (IH)/Type2 Diabetes (T2D), 2025 has been certified by the CPD Certification Service as conforming to continuing professional development principles.

Back to Main page

CME Live Webinar
Updated Guidelines for the management of Intermediate Hyperglycaemia (IH)/Type 2 Diabetes (T2D), 2025

Launch 28 May 2026

Faculty

Antonio Ceriello

Antonio Ceriello

Research Consultant
IRCCS MultiMedica, Milan, Italy
Adjunt Professor of Internal Medicine
“Luigi Vanvitelli University” of Naples
Naples, Italy and
Guang Ci Professor at Ruijin Hospital,
Shanghai Jiao Tong University School of Medicine,
China
Biography
Stephen Colagiuri

Stephen Colagiuri

Professor Emeritus and Co-Director
of the WHO Collaborating Centre on Physical Activity,
Nutrition and Obesity
Charles Perkins Centre and Faculty of Medicine and Health
University of Sydney
Sidney, Australia
Biography
Linong Ji

Linong Ji

Professor of Medicine at Peking University
Director of Peking University Diabetes Center and
Director of the Department of Endocrinology and Metabolism
Peking University People’s Hospital
Beijing, China
Biography

International Committee

Edgar Vicente Mora Brito

Edgar Vicente Mora Brito

President of the Latin American Diabetes Association (ALAD)
Coordinator of Teaching and Research
Hospital General Puyo
Puyo, Pastaza, Ecuador
Biography
Naim Shehadeh

Naim Shehadeh

President of the Israeli Diabetes Association
and Head of the "Galilee Diabetes Sphere" initiative
Azrieli Faculty of Medicine, Bar-Ilan University
Ramat Gan, Israel
Biography
Kohjiro Ueki

Kohjiro Ueki

President of the Japan Diabetes Society
Director of the Diabetes Research Center, National Center for Global Health and Medicine
Japan Institute for Health Security
Tokyo, Japan
Biography

Partnerships & Endorsements

With the endorsement of the Diabetes and Cardiovascular Disease (D&CVD) Study Group

Final Programme

Download

Agenda

AGENDA

FUNDING

· Martin O. Savage ·

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.  His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 60 countries and has published 482 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.

· Antonio Ceriello ·

Antonio Ceriello is Research Consultant at IRCCS MultiMedica, Milan, Italy, Adjunt Professor of Internal Medicine at Luigi Vanvitelli University of Naples, Italy and Guang Ci Professor at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China. Professor Ceriello has published widely in the area of diabetes with over 500 original papers and with an h-index of 110 (SCOPUS). He chaired the International Diabetes Federation (IDF) committee for the development in 2008, and in the 2011 for the update of “Guideline for Management of Postmeal Glucose ”. Currently, is the President of the European Association for the Study of Diabetes (EASD) Study Group on “Diabetes and Cardiovascular Diseases”. He also served as Board member of the “2019 European Society of Cardiology (ESC) guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD “. He also served as Associate Editor of “Diabetes Care” from 2003 to 2011 and Associate Editor of “Diabetic Medicine” from 2005 to 2016. From July 1st 2016 he has been appointed as Editor in Chief of “Diabetes Research and Clinical Practice”, the official IDF journal. Prof. Ceriello has also been appointed by IDF as Co-Chairman for the development of the “2025 Global Clinical Practice Recommendations for the Management of Type 2 Diabetes” and as Chairman for the 2025 IDF World Congress, in 2025 by EASD as Member of the Committee on Clinical Affairs (CCA) for 2025-2028 and delegate as representative of EASD at European Medical Agency (EMA). Prof. Ceriello is the winner of the 2004 “Camillo Golgi Prize” of the EASD, of the 2017 of the “Hellmut Mehnert Award”, during the IDF 2017 Meeting, in the 2022 of the “Aretaeus Lecture Award” from the Hellenic Society of Diabetology, in 2023 of the “Somogyi Award” from the Hungarian Diabetes Association and in of the 2024 “Shaukat Sadikot Oration” at Diabetes India Congress.

· Stephen Colagiuri ·

Stephen Colagiuri is Professor Emeritus and Co-Director of the WHO Collaborating Centre on Physical Activity, Nutrition and Obesity, Charles Perkins Centre and Faculty of Medicine and Health, University of Sydney. His research focus is evidence-based diabetes prevention and care. He served as Vice-President (Physician) on the Board of the International Diabetes Federation (2017 to 2022) and on a number of WHO technical advisory groups. He is a member of the IDF Obesity Taskforce.

· Linong Ji ·

Linong Ji is Professor of Medicine at Peking University, Director of the Peking University Diabetes Center, and Director of the Department of Endocrinology and Metabolism at Peking University People’s Hospital. He holds prominent academic positions including Co-Chairman of the Chinese Cardio-Metabolic Association, Co-Executive President of the China Obesity Federation, and leadership roles in several national medical associations. He also serves on the executive board of the Asia Association for the Study of Diabetes and previously held senior positions such as Chair of the International Diabetes Federation Western Pacific Region, President of the Chinese Diabetes Society, and Vice President of IDF Global. He obtained his MD from Beijing Medical University in 1986 and completed postdoctoral training at the Joslin Diabetes Center, Harvard Medical School. His research concentrates on genetics of diabetes , translational research, and novel pharmacological treatments for diabetes and obesity. As Principal Investigator of over 150 clinical trials, he has published more than 700 peer-reviewed articles. He has been recognized as an Elsevier Highly Cited Scholar in China (2020–2025) and ranked among the world’s top 2% scientists（2022-2025）. He is Chief Editor of the Chinese Diabetes Journal and serves on the editorial boards of multiple leading international diabetes journals.

· Edgar V. Mora Brito ·

Edgar Vicente Mora Brito is an internal medicine specialist and academic leader currently serving as Coordinator of Teaching and Research at Hospital General Puyo. He earned his medical degree and specialization in Internal Medicine from the Central University of Ecuador and holds multiple postgraduate qualifications, including master’s degrees in Healthcare Quality Management and Higher Education Teaching.
Dr. Mora Brito has extensive experience in clinical practice, medical education, and research, with a strong focus on metabolic disorders, diabetes, and chronic disease management. He has authored more than 20 scientific publications and has played a key role in the development of national and international clinical practice guidelines, collaborating with institutions such as the Ministry of Public Health of Ecuador, the Latin American Diabetes Association (ALAD), and the International Diabetes Federation (IDF).
A recognized leader in the field of diabetes, he has held prominent positions including President of the Ecuadorian Diabetes Federation (Amazon Region) and currently serves as President of the Latin American Diabetes Association (ALAD) for the 2025–2028 term. He is also a member of the Guidelines International Network (GIN) and has completed advanced training in the design and interpretation of clinical trials at Johns Hopkins University.
His academic activities include serving as an associate professor and teaching in multiple undergraduate and postgraduate medical programs across Ecuador. He has contributed to the training of healthcare professionals through roles in institutions such as the National University of Loja, the Technical University of Ambato, ESPOCH, and other leading universities. His teaching focuses on evidence-based medicine, diabetes, and chronic disease management, reflecting his strong commitment to advancing medical education and research.
Dr. Mora Brito’s work has been recognized with multiple research awards and scientific distinctions for his contributions to diabetes prevention and chronic disease research at both national and international levels.

· Naim Shehadeh ·

Naim Shehadeh is a Professor of Medicine, President of the Israeli Diabetes Association, and Head of the “Galilee Diabetes Sphere” initiative at the Azrieli Faculty of Medicine, Bar-Ilan University. He graduated from the Rappaport Faculty of Medicine at the Technion and completed his clinical training in Pediatrics and Endocrinology at Rambam Health Care Campus, with further specialization at the University of Colorado Health Sciences Center and Yale University. His expertise covers pediatrics, endocrinology, and diabetes in both children and adults. His research focuses on the pathogenesis and genetics of Type 1 and Type 2 diabetes, innovative treatments to improve disease control and prevent complications, the effects of oral insulin on the gastrointestinal system, and promoting health education and equitable access to care for underserved populations.

· Kohjiro Ueki ·

Kohjiro Ueki MD. PhD. graduated from medical school at the University of Tokyo in 1987. He worked as a physician and diabetologist at the University of Tokyo and obtained PhD degree there. In 1997, he joined Joslin Diabetes Center as a postdoctoral fellow and became Instructor in 2001. In 2004, he became Associate Professor at the Department of Diabetes and Metabolic Diseases at the University of Tokyo, through 2014, and became Professor at the Department of Molecular Sciences on Diabetes in 2014. Since 2016, he has been working at Diabetes Research Center, National Center for Global Health and Medicine (renamed as Japan Institute for Health Security in 2025), as Director. He also served as Professor at Department of Molecular Diabetology, the University of Tokyo from 2020 to 2026. At the Japan Diabetes Society, he has served as Chair of the Board of Directors since 2020.

Join our Newsletter!

Stay in the know with our CME updates

Powered by  GDPR Cookie Compliance (opens in a new tab)
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.